Board member Lars Munch has been appointed as the new Vice-Chair after Marianne Philip. In addition, Nana Bule (picture, right), former CEO of Microsoft Denmark, and MIT Professor Christopher A. Voigt (picture, left) will be joining the Board as new members.
Marianne Philip’s decision to leave the Novo Nordisk Foundation’s Board of Directors comes as she has been appointed as Chair of the BioInnovation Institute Foundation (BII).
Marianne originally joined the Novo Nordisk Foundation’s Board in 2014, and since July 2018 – when Lars Rebien Sørensen was elected Chair – she has served as its Vice-Chair.
“I would like to thank Marianne for the tremendous work she has carried out for the Novo Nordisk Foundation during the last nine years,” says Lars Rebien Sørensen and continues: “As part of the Chairmanship and the Board, she has played a key role in driving the development that has brought the Foundation to where it is today. At the same time, I am thrilled that Marianne has accepted the offer of becoming the new Chair of BII.”
Board member Lars Munch has been appointed as the Novo Nordisk Foundation’s new Vice-Chair. Lars Rebien Sørensen notes: “Lars joined the Board in 2017 and has consistently contributed with his vast knowledge and extensive board experience. I look forward to working even more closely together with him as part of the Chairmanship.”
Two new profiles join the Board
Two new members will be joining the Foundation’s Board of Directors: Nana Bule and Christopher A. Voigt.
Nana Bule comes with a distinguished career spanning more than 20 years at Microsoft Corporation. She originally joined the firm as a technology specialist in 2002, and eventually became the CEO of Microsoft in Denmark and Iceland in 2019. In addition to this, she serves on the boards of Arla Foods and Energinet, as well as being Chair of the National Digital Council and chairing the Committee on Green Transition & Climate Policy at the Confederation of Danish Industry. Nana Bule has a BSc in Business Economics and Strategy from Copenhagen Business School.
Christopher A. Voigt is a Professor of Advanced Biotechnology at the Department of Biological Engineering, Massachusetts Institute of Technology (MIT), and is a founder of Pivot Bio and Asimov, which develop sustainable fertilisers and therapeutic manufacturing, respectively. His research interests include synthetic biology, biotechnology and genetic design. He is the author of numerous research publications and has served on various scientific advisory boards.
Lars Rebien Sørensen notes: “I would like to extend a big welcome to the two new members of our Board. Both have impressive track records, and I look forward to our collaboration. I am confident that they will become a valuable asset for the Foundation’s work.”